Long-term follow-up for patients with COPD in Kingston

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort aims to establish a long-term multidimensional follow-up for patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD) in Kingston, Ontario. The study will collect comprehensive clinical, laboratory, physiological, and radiological data from patients attending the Respirology clinic. Specific objectives include developing a straightforward follow-up protocol, hiring a research assistant, and setting up a database to facilitate ongoing patient management and research. The data gathered will help improve the understanding and treatment of COPD and its comorbidities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients ages between 40-85 years old.
2. Smoking history of at least 10 pack year history
3. Active of former smokers
4. Diagnosis of COPD according to the GOLD definition (4): post bronchodilator spirometry FEV1/FVC ≤0.70, including those with other associated respiratory diseases like asthma, bronchiectasis, stable lung cancer or Interstitial Lung Disease.
5. Ability to perform all study procedures (complete pulmonary function tests, six minute walking test (6MWT) and chest computed tomography) and provide/sign informed consent.

Exclusion Criteria:

1. Patients not willing to sign the consent form
2. Patients with a life expectancy of less than 3 yrs.
3. Patients in palliative care.
4. Patients with chronic airway obstruction ie: FEV1/FVC≤0.70 of other etiology and without a smoking history of less than 10 packs year history.
5. Patients unable ort not able to perform the pulmonary function test, the 6MWT or the chest CT.

Where it's running

• Khsc
  Kingston, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Juan P de Torres, MD — Queen's University
• Study coordinator: Juan P de Torres, MD
• Email: jpdt@queensu.ca
• Phone: 613 549 6666

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Implant to help adults with severe emphysema

  This study will test whether an implantable artificial bronchus can improve breathing and safety in adults with severe COPD/emphysema.

  Recruiting at 4 sites Pulmair Medical, Inc. · San Francisco, California and 3 other locations · NCT07119229

• Implantable Artificial Bronchus 50 Flex for adults with severe emphysema

  This tests a small implant called the IAB 50 Flex to see if it is safe and helps adults with severe COPD or emphysema breathe and move more easily.

  Recruiting at 2 sites Pulmair Medical, Inc. · Limoges and 1 other locations · NCT07086339

• Multidisciplinary sarcopenia clinic to diagnose and treat muscle loss from COPD

  This project will try a multidisciplinary sarcopenia clinic to see if it improves muscle mass, function, and overall health for COPD patients with CT-confirmed muscle loss after a hospitalization.

  Recruiting The Cleveland Clinic · Cleveland, Ohio · NCT07059637

• Bronchoscopic release of trapped air in hyperinflated emphysematous lungs

  This trial tests if placing permanent Apreo BREATHE airway scaffold implants by bronchoscopy, together with usual medical care, helps adults with COPD and emphysema who remain short of breath from lung hyperinflation.

  Recruiting at 23 sites Apreo Health, Inc. · Birmingham, Alabama and 22 other locations · NCT06891755

• Lung cancer screening program for patients with COPD or emphysema

  This study is testing if regular lung cancer screenings can help people with COPD or emphysema catch lung cancer earlier and live longer.

  Recruiting at 2 sites Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Madrid and 1 other locations · NCT06690385

• Endobronchial thermal liquid ablation for treating emphysema

  This study is testing a new treatment called endobronchial thermal liquid ablation to see if it can safely help people with severe emphysema breathe better and improve their quality of life.

  Recruiting at 2 sites Morair Medtech, LLC · Vienna, Austria and 6 other locations · NCT06655428

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.